$40.40 -0.36 (%) Abbott Laboratories - New York Stock Exchange, Inc.

Jan. 19, 2017 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. 5 TSX Tech Stocks With Explosive (+285%) Expected Earnings Growth

    TalkMarkets | Jan. 19, 2017 | 15:27PM EST
  2. AbbVie Leads 3 Other Dividend Aristocrats Going Ex-Dividend This Week

    Dividend.com | Jan. 9, 2017 | 08:00AM EST
  3. Stocks Going Ex Dividend The Second Week Of January

    TalkMarkets | Jan. 7, 2017 | 17:42PM EST
  4. My 7 Favorite Dividend Health Care Stocks Today

    TalkMarkets | Jan. 5, 2017 | 16:38PM EST
  5. These 7 Notable Stocks Going Ex-Dividend Next Week

    TalkMarkets | Jan. 4, 2017 | 10:50AM EST
  6. Bargain Hunting: The 10 Worst Performing Dividend Achievers Of 2016

    TalkMarkets | Dec. 31, 2016 | 18:50PM EST
  7. The Dow Jones Industrial Average Once Again Flirted With The Widely-Watched 20,000 Level

    TalkMarkets | Dec. 28, 2016 | 01:00AM EST
  8. The 10 Best Dividend Aristocrats for 2017 and Beyond

    TalkMarkets | Dec. 22, 2016 | 17:17PM EST
  9. The 10 Best Dividend Achievers

    TalkMarkets | Dec. 14, 2016 | 17:52PM EST
  10. Dividend Income Update November 2016

    TalkMarkets | Dec. 4, 2016 | 21:02PM EST
  11. Dividend Aristocrats In Focus Part 29: Abbott Laboratories

    TalkMarkets | Nov. 3, 2016 | 11:54AM EST
  12. Dividend Aristocrats In Focus Part 28: Abbvie

    TalkMarkets | Nov. 3, 2016 | 10:25AM EST
  13. Morgan Stanley Beats Estimates, Abbott Laboratories Just Ahead

    TalkMarkets | Oct. 19, 2016 | 09:31AM EST
  14. The Market Glance For October 17th: Will IBM Sing the Blues?

    Dividend.com | Oct. 17, 2016 | 09:00AM EST
  15. Stocks Going Ex Dividend The Second Week Of October

    TalkMarkets | Oct. 9, 2016 | 18:47PM EST
  16. J&J Finally Returning to Its Roots in Diversity?

    GuruFocus | Sep. 26, 2016 | 11:04AM EST
  17. Pharma Stock Roundup: Allergan Acquisitions in Focus, J&J to Buy Abbott's AMO

    TalkMarkets | Sep. 23, 2016 | 12:15PM EST
  18. Don’t Worry, AbbVie Will Be Just Fine

    Dividend.com | Aug. 31, 2016 | 08:00AM EST
  19. Mylan Will Buy Meda For $9.9 Billion, Q4 Earnings Miss; Stock Dives

    IBD | Feb. 10, 2016 | 17:30PM EST
  20. Valeant's Share Price Continues to Decline

    GuruFocus | Feb. 5, 2016 | 15:10PM EST
  21. Benzinga's M&A Chatter for Monday February 1, 2015

    Benzinga | Feb. 1, 2016 | 19:53PM EST
  22. Mid-Afternoon Market Update: Roper Technologies Falls Following Weak Results; Questar Shares Spike Higher

    Benzinga | Feb. 1, 2016 | 14:37PM EST
  23. Mid-Day Market Update: Crude Oil Drops Over 4%; Alere Shares Gain On Acquisition News

    Benzinga | Feb. 1, 2016 | 12:23PM EST
  24. Benzinga's Volume Movers

    Benzinga | Feb. 1, 2016 | 10:26AM EST
  25. Mid-Morning Market Update: Markets Open Lower; Abbott Laboratories To Buy Alere For $56/Share

    Benzinga | Feb. 1, 2016 | 10:11AM EST
  26. Benzinga's Top Downgrades

    Benzinga | Jan. 29, 2016 | 09:25AM EST
  27. Earnings Recap For January 28

    Benzinga | Jan. 28, 2016 | 16:34PM EST
  28. Mid-Day Market Update: Facebook Surges On Strong Results; ServiceNow Shares Slip

    Benzinga | Jan. 28, 2016 | 12:00PM EST
  29. Earnings Scheduled For January 28, 2016

    Benzinga | Jan. 28, 2016 | 04:04AM EST
  30. Experienced Insider Continues to Buy Absolute Software

    GuruFocus | Jan. 24, 2016 | 18:18PM EST
  31. Expect Conservative Guidance For Medical Tech Stocks?

    Benzinga | Jan. 22, 2016 | 11:11AM EST
  32. Gilead, Other Biotechs Selling Off On Market Weakness

    Benzinga | Jan. 4, 2016 | 14:22PM EST
  33. Benzinga's Top Downgrades

    Benzinga | Jan. 4, 2016 | 09:32AM EST
  34. US Stock Futures Signal Lower Start On Wall Street

    Benzinga | Jan. 4, 2016 | 07:32AM EST
  35. Barron's Recap: The Outlook For 2016

    Benzinga | Dec. 13, 2015 | 16:12PM EST
  36. Abbott a Dividend Aristocrat Stock Propelled by Emerging Markets

    GuruFocus | Dec. 11, 2015 | 18:34PM EST
  37. Hologic Upgraded On 'Multi-Year Growth' Prediction

    IBD | Dec. 11, 2015 | 12:40PM EST
  38. Jefferies Says It's Buying Abbott Labs Stock On Emerging Market Growth, Valuation

    Benzinga | Dec. 7, 2015 | 10:34AM EST
  39. Benzinga's Top Upgrades

    Benzinga | Dec. 7, 2015 | 08:59AM EST
  40. GoPro PT Cut; Chipotle, Bluebird Bio Downgraded

    IBD | Dec. 7, 2015 | 08:56AM EST
  41. US Stock Futures Edge Higher; Crude Oil Slides

    Benzinga | Dec. 7, 2015 | 06:47AM EST
  42. Time To Buy Mylan's Clear Path To EPS Upside, JP Morgan Says

    Benzinga | Nov. 18, 2015 | 10:22AM EST
  43. Goldman Is Downgrading Abbott Laboratories

    Benzinga | Nov. 13, 2015 | 09:56AM EST
  44. Benzinga's Top Downgrades

    Benzinga | Nov. 13, 2015 | 08:39AM EST
  45. Boston Scientific Pops As Growth Beats FX Headwinds

    IBD | Oct. 28, 2015 | 12:37PM EST
  46. 10 Stocks To Watch For October 21, 2015

    Benzinga | Oct. 21, 2015 | 03:58AM EST
  47. Earnings Scheduled For October 21, 2015

    Benzinga | Oct. 21, 2015 | 03:09AM EST
  48. McDonald's Mulls Real Estate Move Amid REIT Calls

    IBD | Oct. 15, 2015 | 17:02PM EST
  49. Benzinga's Top Upgrades

    Benzinga | Oct. 7, 2015 | 08:37AM EST
  50. Barclays Upgrades Abbott, Sees 'Selling Overdone'

    Benzinga | Oct. 7, 2015 | 07:28AM EST
Trading Center